Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Endocannabinoids (eCBs) / The Endocannabinoid System (eCB) & Mental disorder / Psychiatric disorders

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

Recently, the Endocannabinoids (eCBs) / The Endocannabinoid System (eCB) system and the gut microbiota dysfunctions were also reported in Mental disorder / Psychiatric disorders
Guida et al. 2018a Brain Behav. Immun. 67: 230-245
Markey et al. 2020a Psychoneuroendocrinology 121: 104808

The Endocannabinoids (eCBs) / The Endocannabinoid System (eCB) system dysregulation in the CNS has been increasingly implicated in the physiopathology of [neurodegenerative and neuropsychiatric disorders](brain://ofBOKiqUIUmoBN3-r92q9g/Neurod…

References (Sources)

Antibiotic-Induced Microbiota Perturbation Causes Gut Endocannabinoidome Changes, Hippocampal Neuroglial Reorganization and Depression in Mice
Guida et al. 2018a Brain Behav. Immun. 67: 230-245
Colonization with the Commensal Fungus Candida Albicans Perturbs the Gut-Brain Axis through Dysregulation of Endocannabinoid Signaling
Markey et al. 2020a Psychoneuroendocrinology 121: 104808
Critical Review of the Role of the Cannabinoid Compounds ∆9-Tetrahydrocannabinol (∆9-THC) and Cannabidiol (CBD) and Their Combination in Multiple Sclerosis Treatment
Jones et al. 2020 Molecules 25: 4930
Review
Endocannabinoid System Alterations in Alzheimer’s Disease: A Systematic Review of Human Studies
Berry et al. 2020a Brain Res. 1749:147135
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention
Leweke et al. 2018 CNS Drugs 32: 605-619
The Endocannabinoid System in Guarding against Fear, Anxiety and Stress
Lutz et al. 2015 Nat. Rev. Neurosci. 16: 705-718
Review
The Endocannabinoid System: A Bridge between Alzheimer’s Disease and Gut Microbiota
Bisogno et al. 2021 Life 11: 934
Review

AI Chat

7/1/2026

Chat with our artificial intelligence: